Clinical trial

Alternate Day Versus Daily Oral Iron Therapy in Adolescents With Iron Deficiency Anemia and Heavy Menstrual Bleeding: A Feasibility Trial

Name
H - 46363
Description
Iron deficiency anemia affects over half of girls and young women with heavy periods and is the most common cause of anemia worldwide. Most girls with heavy periods who also have iron deficiency anemia are prescribed iron to take by mouth every day by their doctor. There are some studies showing that taking iron every other day may actually help the iron be absorbed into the bloodstream better. This study is trying to compare how taking iron every other day compares to taking iron daily for treatment of anemia. The goal of this clinical research study is to learn which of the two methods of care will be the best way for girls and young women with iron deficiency anemia to take iron supplementation.
Trial arms
Trial start
2020-12-21
Estimated PCD
2022-06-30
Trial end
2022-12-22
Status
Completed
Phase
Early phase I
Treatment
Ferrous sulfate
Alternate day dosing of ferrous sulfate
Arms:
Alternate Day, Daily
Other names:
Fer-In-Sol, Feratab, Iron, Feosol
Size
13
Primary endpoint
Percentage of Eligible Patients Enrolled.
At enrollment
Eligibility criteria
Inclusion Criteria: 1. Age 9 years or greater and less than age 22 years 2. Heavy menstrual bleeding, defined as a Pictorial Blood Assessment Chart (PBAC) Score \>100 3. Iron deficiency anemia, defined as both hemoglobin \<12 g/dL and ferritin \<15 ng/mL within 7 days of enrollment. Exclusion Criteria: 1. non-uterine cause of vaginal bleeding 2. pregnancy 3. chronic kidney disease 4. serology confirmed celiac disease 5. active gastrointestinal blood loss 6. active malignancy 7. inability to follow-up at Texas Children's Hospital 8. receipt of intravenous iron within 30 days prior to enrollment 9. allergy or known inability to tolerate oral iron
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['PHASE4'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'primaryPurpose': 'OTHER', 'maskingInfo': {'masking': 'NONE'}}, 'enrollmentInfo': {'count': 13, 'type': 'ACTUAL'}}
Updated at
2023-09-13

1 organization

1 product

3 indications